Skip to main navigation Skip to search Skip to main content

Association between serum soluble tumor necrosis factor receptor and short-term treatment response in first-episode schizophrenia

  • The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To explore the role of soluble tumor necrosis factor receptors (TNFR) 1 and 2 in the diagnosis of schizophrenia and the prediction of short-term therapeutic effect of antipsychotics. Methods: ELISA was used to detect serum sTNFR1 and sTNFR1 concentrations in the patients with schizophrenia before (n=49) and after six-week treatment (n=26), as well as in the healthy controls. The positive and negative syndrome scale (PANSS) was used to measure initial symptom severity and the therapeutic effect of antipsychotics. Then, the correlation of PANSS score with sTNFR1 and sTNFR1 levels was analyzed. Results: Both serum sTNFR1 and sTNFR2 levels were higher in the patients with schizophrenia than in the controls (P<0.001). Serum sTNR1 was significantly associated with the total score of PANSS and the score of positive syndrome of PANSS (rs: 0.27-0.56, P<0.034). Moreover, the responders to six-week treatment with antipsychotics displayed significantly decreased serum sTNFR1 concentration than those non-responders (P<0.0001), and the decrease in sTNFR1 concentration along with the treatment showed a positive correlation with improvement in PANSS (rs=0.679, P<0.01). Conclusion: The abnormally higher serum sTNFR1 level may be closely correlated with the symptom severity and the alteration in serum sTNFR1 level has a predictive value for the therapeutic response to psychotics.

Original languageEnglish
Pages (from-to)708-711
Number of pages4
JournalJournal of Xi'an Jiaotong University (Medical Sciences)
Volume37
Issue number5
DOIs
StatePublished - 5 Sep 2016
Externally publishedYes

Keywords

  • Initial schizophrenia
  • Positive and negative syndrome scale (PANSS)
  • Soluble tumor necrosis factor receptor
  • Therapeutic response

Fingerprint

Dive into the research topics of 'Association between serum soluble tumor necrosis factor receptor and short-term treatment response in first-episode schizophrenia'. Together they form a unique fingerprint.

Cite this